Replies to post #168337 on Biotech Values

[dewophile]

they did add arms for GT1 cirrhotics in this large phase 2. not sure if it will be enough for the NDA

http://www.clinicaltrials.gov/ct2/show/NCT01260350?term=sofosbuvir+cirrhosis&rank=6

this is the open phase 3 in this population, which may or may not be rate limiting for filing the NDA:

http://www.clinicaltrials.gov/ct2/show/NCT01938430?term=sofosbuvir+cirrhosis&rank=5